Zilart 250 mg tablete za oralnu suspenziju
| Name | Zilart 250 mg tablete za oralnu suspenziju |
|---|---|
| Marketing Authorisation Number | HR-H-379666860 |
| Active Substance | deferasiroks |
| Composition | svaka tableta za oralnu suspenziju sadrži 250 mg deferasiroksa |
| Pharmaceutical Form | tableta za oralnu suspenziju |
| Packaging [MA Number for Packaging] | 28 tableta u blisteru, u kutiji [HR-H-379666860-01] 84 tablete u blisteru, u kutiji [HR-H-379666860-02] 252 tablete u blisteru, u kutiji [HR-H-379666860-03] |
| Manufacturer | Pharmascience International Limited, Nicosia, Cipar |
| Marketing Authorisation Holder | Makpharm d.o.o., Trnjanska cesta 37/1, Zagreb, Hrvatska |
| Marketing Authorisation Date | 31.05.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/123 |
| Registration Number | 381-12-01/154-23-06 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | V03AC03 |
| Medicinal product marketed in the Croatia | Ne |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Educational materials for healthcare professionals |
Brošura za zdravstvene radnike, verzija 1 |
| Educational materials for patients / caregivers |
Brošura za bolesnike, verzija 1 |
